Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3425 AUD | -0.72% | +2.99% | +68.29% |
01/05 | Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication | MT |
22/04 | Dimerix Posts AU$35.2 Million Cash, AU$3.3 Million Operating Cash Outflows for March Quarter | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+68.29% | 130M | |
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication